DNMT3A and acute myeloid leukemia: Furthermore, our cohort of AML patients with DNMT3A mutations had older age and higher WBC and PLT counts, which was consistent with the study of the German–Austrian cohort [23], but there was no difference in the male-to-female ratio of our cohort, and the BM blast cell percentages were not significantly increased (p = 0.0862) [23].